Biocon Ltd.

₹370.5

5.2 (1.4%)

BIOCON Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 59,915 Cr

P/E Ratio43.9

Dividend Yield0.03 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	367.96	Bullish
10-DMA	371.67	Bearish
20-DMA	378.73	Bearish
50-DMA	388.82	Bearish
100-DMA	376.59	Bearish
200-DMA	364.55	Bullish

Historical Performance

1 Year

2.9%

3 Years

57.3%

5 Years

-2.5%

10 Years

351.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,52,617	1,47,557	1,11,742	81,840	71,431
Total Expenditure	1,22,430	1,15,590	90,547	66,914	58,410
Other Income	13,558	9,675	7,681	6,903	6,052
Operating Profit	43,745	41,642	28,876	21,829	19,073
Interest	8,974	9,744	4,190	676	577
Depreciation	16,870	15,688	11,131	8,142	7,151
Profit Before Tax	18,866	15,252	8,971	9,831	10,677
Consolidated Net Profit	10,133	10,225	4,627	6,484	7,405
Adjusted EPS	8	9	4	5	6

Compounded Sales Growth

10 Years:37.6

5 Years:19.4

3 Years:13.3

TTM:0.7

Compounded Profit Growth

10 Years:15.3

5 Years:6.3

3 Years:9.3

TTM:-0.2

Stock Price CAGR

10 Years:16.3

5 Years:-0.1

3 Years:16.3

TTM:4.2

Return on Equity

10 Years:4.6

5 Years:6.2

3 Years:3.9

last year:8.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	6,003	6,003	6,003	6,003	6,000
Total Reserves	2,06,188	1,88,633	1,69,926	76,281	68,728
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,64,933	1,51,198	2,07,423	68,027	54,969
Other Current Liabilities	39,657	64,812	18,149	10,312	18,402
Short Term Borrowings	34,547	21,492	24,802	8,960	5,942
Total Liabilities	5,85,396	5,57,534	5,17,418	2,01,007	1,82,146
Capital Work in Progress	41,017	39,852	25,875	34,203	22,535
Long Term Loans & Advances	8,708	8,925	6,832	4,838	4,364
Currents Investments	4,473	3,156	13,265	12,177	12,130
Short Term Loans and Advances	9,170	10,960	4,564	4,005	2,933
Total Current Assets	1,62,862	1,51,792	1,23,340	83,823	76,004
Total Assets	5,85,396	5,57,534	5,17,418	2,01,007	1,82,146
Adjusted Book Value	177	162	147	69	62

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 43.9, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 16.6%, indicating sustained price appreciation.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹43745 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹152617 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1041608.1

No. of Shares: 2811 (Approx)

Performance:4.2%

P/L: ₹41608.1

NIFTY Performance: 9.4%

1 day Top Gainers